I agree it is very advantageous to Novatti for Reckon to use this sale funds to enhance something we both benefit from. Yes, we get a dividend and working capital, but the real value is the money reckon now have to grow our partnership and their offering.
a really good/low risk deal for us.
I agree it is very advantageous to Novatti for Reckon to use...
Add NOV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $13.81M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.3¢ | $56.37K | 1.624M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 786999 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 115541 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NOV (ASX) Chart |